Merck's Gardasil 9 launches in Canada; Immunomic wins NIH grant for peanut allergy candidate;

> Merck's ($MRK) Gardasil 9 has launched in Canada. Release

> Immunomic Therapeutics has won a Small Business Innovation Research grant from the NIH for its work on a peanut allergy vaccine. Release

> Diabetes vaccine maker Diamyd Medical has received 15 million Swedish krona ($1.7 million) in a direct issue. Release

> The human vaccine market in China is slated to jump as R&D and production capacity grow. Release

And Finally... Geovax has assigned a trial number to the next study of its candidate HIV preventive. Release

Read more on